Business Context and Reporting Period
Company: Central Garden & Pet Company
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: December 29, 2001 (First Quarter of Fiscal Year 2002)
Business Overview: The Company operates in two reportable segments: Garden Products and Pet Products. The Company is currently undergoing a strategic realignment, integrating its distribution operations into its proprietary product businesses following the termination of its distribution agreement with The Scotts Company in September 2000.
Key Financial Metrics
| Metric (in thousands) | Q1 2002 (Ended Dec 29, 2001) | Q1 2001 (Ended Dec 30, 2000) |
|---|---|---|
| Net Sales | $210,659 | $212,058 |
| Gross Profit | $71,786 | $64,780 |
| Gross Margin | 34.1% | 30.5% |
| Operating Income | $1,881 | $(2,266) |
| Net Loss | $(1,509) | $(4,452) |
| Loss Per Share (Basic & Diluted) | $(0.08) | $(0.24) |
| Cash & Equivalents | $5,692 | $8,292 |
| Total Debt (Current + Long-term) | $178,762 | $178,098 |
| Net Cash Used in Operating Activities | $(1,350) | $(11,814) |
Material Changes vs. Prior Period
- Revenue: Net sales decreased slightly by 0.7% ($1.4 million) to $210.7 million. The Pet Products segment declined due to the termination of the Kal Kan distribution agreement and closure of four distribution centers, partially offset by a $4.6 million increase in Garden Products sales.
- Profitability: The Company returned to operating profitability ($1.9 million) compared to an operating loss of $2.3 million in the prior year. Gross profit increased by 10.8% ($7.0 million), driven by higher-margin product sales in Pet Products (Wellmark and Kaytee brands) and improved margins in Garden Products.
- Expenses: Selling, general, and administrative (SG&A) expenses increased 4.3% to $69.9 million. This increase was largely due to higher warehouse and administrative costs ($2.4 million increase) resulting from lower inventory levels shifting costs from inventory to expense. However, corporate expenses decreased by $0.4 million, primarily due to the elimination of goodwill amortization ($2.7 million) following the adoption of SFAS No. 142.
- Interest Expense: Net interest expense decreased by $2.0 million to $3.9 million, attributed to lower average short-term borrowings ($114.0 million vs. $142.9 million) and lower interest rates (5.0% vs. 8.5%).
- Cash Flow: Cash used in operating activities improved significantly, decreasing from $11.8 million to $1.4 million, driven by reduced seasonal inventory buildup and improved receivables collection.
Guidance, Outlook, Risks, and Unusual Items
- Accounting Changes: The Company adopted SFAS No. 142 (Goodwill and Other Intangible Assets) effective September 30, 2001, ceasing goodwill amortization. An initial impairment assessment is required by the end of the second quarter of fiscal 2002; no determination has been made as of the filing date.
- Litigation Risks:
- Scotts Company: Ongoing litigation regarding the termination of the distribution relationship. Scotts seeks $23 million; Central has counterclaims. Trial is scheduled for March 2002. Central believes the aggregate resolution will not result in additional charges but acknowledges uncertainty.
- Pharmacia/Monsanto: Settled for $5.5 million (previously recorded as an obligation). Antitrust claims against Pharmacia and Monsanto were dismissed.
- TFH Publications: Litigation with prior owners regarding earnouts and tax liabilities. Trial scheduled for June 2002. Management does not believe the outcome will be materially adverse.
- Phoenix Fire: A fire at the Phoenix distribution center in August 2000 has resulted in third-party claims for property damage and bodily injury. The total damages are unquantified, but the Company maintains $51 million in third-party liability coverage.
- Liquidity: The Company has a $200 million line of credit with $12.7 million available, an $85 million line for Pennington with $43.6 million available, and a $10 million line for All-Glass Aquarium with $6.2 million available. Management believes current resources are adequate for working capital needs.
- Capital Expenditures: Anticipated to not exceed $15.0 million for the next 12 months.
Investor Verification Checklist
- Goodwill Impairment: Verify the outcome of the SFAS No. 142 impairment assessment required by the end of Q2 2002, as this could result in significant charges.
- Scotts Litigation Outcome: Monitor the March 2002 trial regarding the $23 million claim and Central's counterclaims to assess potential financial impact.
- Phoenix Fire Liabilities: Track the resolution of third-party claims and environmental assessments to ensure insurance coverage remains sufficient.
- Seasonality Impact: Confirm if the reduced seasonality (due to the Scotts termination) holds true in the upcoming peak selling quarters (Q2 and Q3).
- Debt Covenants: Review compliance with financial covenants (minimum net worth and working capital) on the $200 million credit line.